<DOC>
	<DOCNO>NCT00003617</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . It yet know whether chlorambucil effective observation treat low-grade lymphoma stomach . PURPOSE : Randomized phase III trial compare effectiveness chlorambucil therapy follow anti-Helicobacter therapy treat patient low-grade lymphoma stomach .</brief_summary>
	<brief_title>Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy Treating Patients With Low-Grade Lymphoma Stomach</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy response rate triple antibiotic therapy Helicobacter pylorus heal lesion patient low grade gastric lymphoma . II . Assess efficacy chlorambucil prevention relapse patient complete eradication low grade gastric lymphoma . III . Determine natural history unresected partially resect low grade gastric lymphoma treat medically . OUTLINE : This randomize study . Patients randomize receive chlorambucil placebo . Patients receive omeprazole daily 1 week . Clarithromycin tinidazole administer twice daily 1 week eradication H. pylorus infection . Patients assessed every 2-3 month endoscopy . Patients may receive maximum 3 course treatment every 2-3 month . Other regimen may use full eradication H. pylorus achieve . Patients achieve complete response ( eradication H. pylorus ) randomize receive oral chlorambucil placebo daily 14 day . Treatment repeat every 28 day 6 course . Patients follow every 6 month 2 year , yearly thereafter . PROJECTED ACCRUAL : A total 200 patient accrue study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<mesh_term>Chlorambucil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Endoscopically diagnose , unresected , partially resect , completely resect low grade ( stage I ) gastric lymphoma Prior diagnosis H. pylori infection No nodal metastases Microbiological evidence current H. pylorus infection require No pathological evidence enlarge abdominal lymph node CT scan Gastroscopic ultrasound evidence enlarge node allow , CT scan normal PATIENT CHARACTERISTICS : Age : 16 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>stage I gastric cancer</keyword>
</DOC>